TriSalus Life Sciences (TLSI) Institutional Ownership $5.22 0.00 (0.00%) Closing price 04:00 PM EasternExtended Trading$5.24 +0.02 (+0.29%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for TriSalus Life Sciences (NASDAQ:TLSI)CurrentInstitutional OwnershipPercentage2.58%Number ofInstitutional Buyers(last 12 months)13TotalInstitutional Inflows(last 12 months)$4.17MNumber ofInstitutional Sellers(last 12 months)6TotalInstitutional Outflows(last 12 months)$683.62K Get TLSI Insider Trade Alerts Want to know when executives and insiders are buying or selling TriSalus Life Sciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data TLSI Institutional Buying and Selling by Quarter Remove Ads TriSalus Life Sciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/18/2025Connecticut Wealth Management LLC22,303$112K0.0%-32.2%0.073% 2/18/2025Connective Capital Management LLC27,989$140K0.2%N/A0.092% 2/17/2025Millennium Management LLC80,538$403K0.0%-17.7%0.264% 2/17/2025Bridgeway Capital Management LLC65,000$326K0.0%+333.3%0.213% 2/17/2025Bank of America Corp DE178,446$894K0.0%+120,471.6%0.585% 2/17/2025Angelo Gordon & CO. L.P.10,854$54K0.0%-48.0%0.036% 2/14/2025Lido Advisors LLC14,024$70K0.0%-60.0%0.046% 2/14/2025Northern Trust Corp32,112$161K0.0%+22.7%0.105% 2/13/2025Renaissance Technologies LLC13,400$67K0.0%N/A0.044% 2/12/2025Geode Capital Management LLC204,137$1.02M0.0%+1.9%0.670% 11/20/2024Virtu Financial LLC19,875$92K0.0%N/A0.065% 11/16/2024Geode Capital Management LLC200,427$924K0.0%+45.4%0.657% 11/15/2024Vestcor Inc23,376$108K0.0%N/A0.077% 11/15/2024MSD Partners L.P.39,999$184K0.1%N/A0.131% 11/14/2024Walleye Capital LLC14,376$66K0.0%N/A0.047% 8/15/2024Duquesne Family Office LLC426,921$2.36M0.1%+35.1%1.572% 8/12/2024Highbridge Capital Management LLC214,545$1.18M0.0%N/A0.790% 8/2/2024Wolverine Asset Management LLC43,480$240K0.0%N/A0.160% 5/7/2024Anson Capital Inc.24,415$238K0.3%-30.3%0.091% 5/1/2024Connecticut Wealth Management LLC44,606$435K0.0%-22.0%0.167% 4/23/2024Tyche Wealth Partners LLC10,000$98K0.0%-62.5%0.037% 1/30/2024Tyche Wealth Partners LLC26,664$225K0.1%N/A0.101% 1/25/2024HC Advisors LLC101,736$860K0.5%N/A0.387% (Data available from 1/1/2016 forward)Remove Ads TLSI Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of TLSI shares? During the previous two years, 20 institutional investors and hedge funds held shares of TriSalus Life Sciences. The most heavily invested institutionals were Duquesne Family Office LLC ($2.36M), Highbridge Capital Management LLC ($1.18M), Geode Capital Management LLC ($1.02M), Bank of America Corp DE ($894K), HC Advisors LLC ($860K), Millennium Management LLC ($403K), and Bridgeway Capital Management LLC ($326K).Learn more on TLSI's institutional investors. What percentage of TriSalus Life Sciences stock is owned by institutional investors? 2.58% of TriSalus Life Sciences stock is owned by institutional investors. Learn more on TLSI's institutional investor holdings. Which institutional investors have been buying TriSalus Life Sciences stock? Of the 15 institutional investors that purchased TriSalus Life Sciences stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Highbridge Capital Management LLC ($214.55K), Bank of America Corp DE ($178.30K), Duquesne Family Office LLC ($110.97K), HC Advisors LLC ($101.74K), Geode Capital Management LLC ($66.25K), Bridgeway Capital Management LLC ($50K), and Wolverine Asset Management LLC ($43.48K). How much institutional buying is happening at TriSalus Life Sciences? Institutional investors have bought a total of 936,892 shares in the last 24 months. This purchase volume represents approximately $5.26M in transactions. Which TriSalus Life Sciences major shareholders have been selling company stock? The following institutional investors have sold TriSalus Life Sciences stock in the last 24 months: Connecticut Wealth Management LLC ($23.16K), Lido Advisors LLC ($21K), Millennium Management LLC ($17.35K), Tyche Wealth Partners LLC ($16.66K), Anson Capital Inc. ($10.59K), and Angelo Gordon & CO. L.P. ($10K). How much institutional selling is happening at TriSalus Life Sciences? Institutional investors have sold a total of 98,762 shares in the last 24 months. This volume of shares sold represents approximately $683.62K in transactions. Related Companies Iradimed Institutional Ownership Avanos Medical Institutional Ownership OrthoPediatrics Institutional Ownership SI-BONE Institutional Ownership Butterfly Network Institutional Ownership Treace Medical Concepts Institutional Ownership Delcath Systems Institutional Ownership NeuroPace Institutional Ownership Semler Scientific Institutional Ownership ClearPoint Neuro Institutional Ownership This page (NASDAQ:TLSI) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TriSalus Life Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TriSalus Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
